中文(简体)
Albanian
Arabic
Armenian
Azerbaijani
Belarusian
Bengali
Bosnian
Catalan
Czech
Danish
Deutsch
Dutch
English
Estonian
Finnish
Français
Greek
Haitian Creole
Hebrew
Hindi
Hungarian
Icelandic
Indonesian
Irish
Italian
Japanese
Korean
Latvian
Lithuanian
Macedonian
Mongolian
Norwegian
Persian
Polish
Portuguese
Romanian
Russian
Serbian
Slovak
Slovenian
Spanish
Swahili
Swedish
Turkish
Ukrainian
Vietnamese
Български
中文(简体)
中文(繁體)

Therapeutic Substance Abuse Treatment in Pregnancy - 1

只有注册用户可以翻译文章
登陆注册
链接已保存到剪贴板
状态已完成
赞助商
Yale University
合作者
National Institute on Drug Abuse (NIDA)

关键词

抽象

The purpose of this study is... To assess whether a behavioral treatment that combines motivational enhancement and cognitive skills training therapy (MET-CBT) is more effective than brief advice in: 1) decreasing use of a full range of psychoactive substances (e.g. marijuana, cocaine, methamphetamines, alcohol, nicotine, opioids) in pregnant substance using and dependent women; 2) decreasing HIV risk behavior; 3) improving birth outcomes (longer gestations and greater birth weight).

描述

We propose an integrated system of counseling services onsite in primary care obstetrical clinics, comparing a manualized brief advice (closely approximating "treatment as usual") to manualized motivationally enhanced cognitive behavioral therapy. Treatment providers are obstetrical nurses. Therapy patients are taught skill sets designed to enhance motivation to abstain from drugs of abuse, as well as designed to prevent relapse during the perinatal period. It is our hypothesis that therapy patients will be more successful at achieving stated study aims than those receiving brief advice.

日期

最后验证: 03/31/2020
首次提交: 09/26/2005
提交的预估入学人数: 09/26/2005
首次发布: 09/27/2005
上次提交的更新: 03/31/2020
最近更新发布: 04/14/2020
首次提交结果的日期: 06/13/2013
首次提交质量检查结果的日期: 06/13/2013
首次发布结果的日期: 08/20/2013
实际学习开始日期: 08/31/2004
预计主要完成日期: 07/31/2010
预计完成日期: 07/31/2010

状况或疾病

Alcohol Abuse
Cocaine Abuse
Marijuana Abuse

干预/治疗

Behavioral: MI-CBT

Behavioral: Brief Advice

相 2

手臂组

干预/治疗
Experimental: MI-CBT
Motivationally-enhanced cognitive behavioral skills counseling
Behavioral: MI-CBT
Motivationally-enhanced cognitive behavioral skills counseling
Active Comparator: Brief Advice
Advice and education
Behavioral: Brief Advice
Advice and education

资格标准

有资格学习的年龄 16 Years 至 16 Years
有资格学习的性别Female
接受健康志愿者
标准

Inclusion Criteria:

Pregnant women, age 16 or older, alcohol or illicit drug use in the past 30 days -

Exclusion Criteria:

Nonfluent in English or Spanish, pending incarceration, psychotic, cognitively unable to give informed consent, actively suicidal or homicidal, already engaged in addictions treatment, primarily addicted to nicotine or heroin.

-

结果

主要结果指标

1. Percentage of Days Used Drugs or Alcohol [intake to delivery, an average of 21 weeks]

2. Percentage of Days Used Drugs or Alcohol [delivery to 3 months post-delivery]

3. Percentage of Days That Participants (Without a Baseline Diagnosis of Drug Abuse or Dependence) Used Drugs or Alcohol [intake to delivery, an average of 21 weeks]

4. Percentage of Days That Participants (Without a Baseline Diagnosis of Drug Abuse or Dependence) Used Drugs or Alcohol [Delivery to 3 months post-delivery]

5. Percentage of Days That Participants (With a Baseline Diagnosis of Drug Abuse or Dependence) Used Drugs or Alcohol [intake to delivery, an average of 21 weeks]

6. Percentage of Days That Participants (With a Baseline Diagnosis of Drug Abuse or Dependence) Used Drugs or Alcohol [Delivery to 3 months post-delivery]

次要成果指标

1. Incidence of Preterm Births [At delivery]

2. Incidence of Low Birth Weight [At delivery]

3. Proportion of Participants Abstinent From Both Drugs and Alcohol (28 Days Prior to Assessment) According to Self-report [intake to delivery, an average of 21 weeks]

4. Proportion of Participants Abstinent From Both Drugs and Alcohol (28 Days Prior to Assessment) According to Self-report [Delivery to 3 months post-delivery]

5. Proportion of Participants Abstinent From Drugs (i.e., Marijuana, Cocaine or Opioids) According to Urine [intake to delivery, an average of 21 weeks]

6. Proportion of Participants Abstinent From Drugs According to Urine [Delivery to 3 months post-delivery]

Based on urine tests for marijuana, cocaine, or opioids

7. Proportion of Participants Abstinent From Both Drugs and Alcohol According to Combined Self-report and Urine [intake to delivery, an average of 21 weeks]

Based on urine tests for marijuana, cocaine or opioids.

8. Proportion of Participants Abstinent From Both Drugs and Alcohol According to Combined Self-report and Urine [Delivery to 3 months post-delivery]

Based on urine tests for marijuana, cocaine, or opioids.

9. Proportion of Participants (Without a Baseline Diagnosis of Drug Abuse or Dependence) Abstinent From Both Drugs and Alcohol (28 Days Prior to Assessment) According to Self-report [intake to delivery, an average of 21 weeks]

10. Proportion of Participants (Without a Baseline Diagnosis of Drug Abuse or Dependence) Abstinent From Both Drugs and Alcohol (28 Days Prior to Assessment) According to Self-report [Delivery to 3 months post-delivery]

11. Proportion of Participants (With a Baseline Diagnosis of Drug Abuse or Dependence) Abstinent From Both Drugs and Alcohol (28 Days Prior to Assessment) According to Self-report [intake to delivery, an average of 21 weeks]

12. Proportion of Participants (With a Baseline Diagnosis of Drug Abuse or Dependence) Abstinent From Both Drugs and Alcohol (28 Days Prior to Assessment) According to Self-report [Delivery to 3 months post-delivery]

13. Proportion of Participants (Without a Baseline Diagnosis of Drug Abuse or Dependence) Abstinent From Drugs According to Urine [intake to delivery, an average of 21 weeks]

Based on urine tests for marijuana, cocaine or opioids.

14. Proportion of Participants (Without a Baseline Diagnosis of Drug Abuse or Dependence) Abstinent From Drugs According to Urine [Delivery to 3 months post-delivery]

Based on urine tests for marijuana, cocaine or opioids.

15. Proportion of Participants (With a Baseline Diagnosis of Drug Abuse or Dependence) Abstinent From Drugs According to Urine [intake to delivery, an average of 21 weeks]

Based on urine tests for marijuana, cocaine or opioids.

16. Proportion of Participants (With a Baseline Diagnosis of Drug Abuse or Dependence) Abstinent From Drugs According to Urine [Delivery to 3 months post-delivery]

Based on urine tests for marijuana, cocaine or opioids.

17. Proportion of Participants (Without a Baseline Diagnosis of Drug Abuse or Dependence) Abstinent From Both Drugs and Alcohol According to Combined Self-report and Urine [intake to delivery, an average of 21 weeks]

Based on urine tests for marijuana, cocaine or opioids.

18. Proportion of Participants (Without a Baseline Diagnosis of Drug Abuse or Dependence) Abstinent From Both Drugs and Alcohol According to Combined Self-report and Urine [Delivery to 3 months post-delivery]

Based on urine tests for marijuana, cocaine or opioids

19. Proportion of Participants (With a Baseline Diagnosis of Drug Abuse or Dependence) Abstinent From Both Drugs and Alcohol According to Combined Self-report and Urine [intake to delivery, an average of 21 weeks]

Based on urine tests for marijuana, cocaine or opioids

20. Proportion of Participants (With a Baseline Diagnosis of Drug Abuse or Dependence) Abstinent From Both Drugs and Alcohol According to Combined Self-report and Urine [Delivery to 3 months post-delivery]

Based on urine tests for marijuana, cocaine or opioids

其他成果措施

1. Adequacy of Received Services [After prenatal care initiation]

Based on prenatal care attendance: the percent of visits attended after prenatal care initiation, accounting for time of delivery. Attendance was rated according to the Kotelchuck Adequacy of Prenatal Care Index. Only the normally scheduled prenatal car visits were included.

2. Attendance of Treatment Outside the Study [30 days prior to assessment]

The number of patients who attended outside treatment in the 30 days prior to each assessment.

加入我们的脸书专页

科学支持的最完整的草药数据库

  • 支持55种语言
  • 科学支持的草药疗法
  • 通过图像识别草药
  • 交互式GPS地图-在位置标记草药(即将推出)
  • 阅读与您的搜索相关的科学出版物
  • 通过药效搜索药草
  • 组织您的兴趣并及时了解新闻研究,临床试验和专利

输入症状或疾病,并阅读可能有用的草药,输入草药并查看所使用的疾病和症状。
*所有信息均基于已发表的科学研究

Google Play badgeApp Store badge